Linked Life Data

17623721

Source:http://linkedlifedata.com/resource/pubmed/id/17623721

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-10-30
pubmed:abstractText
The conventional method for C-reactive protein (CRP) measurement is an immunoturbidimetric assay (imCRP, detection limit > or =3 mg/l). However, high-sensitivity CRP (hsCRP, detection limit >0.1 mg/l) has been advocated as preferable biomarker for cardiovascular risk assessment. The aim of this study was to determine agreement between imCRP and hsCRP in end-stage renal disease (ESRD) patients, and to examine whether the association between CRP and mortality is comparable when using imCRP or hsCRP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0931-0509
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3277-84
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
pubmed:affiliation
Leiden University Medical Center, Department of Clinical Epidemiology C9-29, P.O. Box 9600 2300 RC Leiden, The Netherlands. d.c.grootendorst@lumc.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study